Centrica PLC has announced that two of its Executive Directors, Christopher O'Shea and Russell O'Brien, have acquired ordinary shares of 614/81 pence under the Company's Share Incentive Plan. The shares were acquired through Equiniti Share Plan Trustees Limited, the administrators of the Plan. The transactions were made on 11th March 2024, with 114 Partnership shares and 22 Matching shares being acquired by each director.
The price per share for the transactions was £1.3134 for Partnership shares and £1.3205 for Matching shares. The total aggregated volume of shares acquired by each director was 136, with an aggregated price of £1.315 per share, amounting to £178.78. The Partnership shares were acquired on the London Stock Exchange, while the Matching shares were acquired outside a trading venue.
Centrica PLC is listed on the London Stock Exchange and its registered office is located at Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD. The company's legal entity identifier number is E26EDV109X6EEPBKVH76.
This notification of the directors' share transactions is in compliance with Article 19 of the Market Abuse Regulation, providing transparency regarding the acquisition of shares by persons discharging managerial responsibilities within the company.